Barclays 27th Annual Global Healthcare Conference Call March 12, 2025 2:00 PM ETCompany ParticipantsBrian Evanko - Chief ...

Mía had dystrophic epidermolysis bullosa, better known as butterfly skin due to the extreme fragility of this tissue in ...

The Swiss pharma group said this morning that the separation "is in the best interest of shareholders" and will create the number one generics company in Europe and a leader in biosimilars ...

The reaction from within the political sphere was immediate, with the White House and President Biden immediately releasing a statement welcoming ... Act’, for example, had provided a guarantee ...

An appeals court has upheld a District Court’s denial of a preliminary injunction for Amgen’s (AMGN) Eylea biosimilar, which UBS analyst Trung ...

The FDA has approved Celltrion’s OMLYCLO (omalizumab-igec) as the first and only biosimilar designated as interchangeable ...

TORONTO--(BUSINESS WIRE)--Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new brand name Remdantry ...

NASA’s Mars Sample Return (MSR) mission promises to fill significant gaps in our understanding of the universe and propel humanity forward in a new phase of the space race. Exploring the cosmos ...

While the two Democratic Commissioners issued a concurring statement asserting the transaction is an example of a “problematic playbook… [of] a private equity” company, the complaint and the ...

Non-communicable diseases (NCDs) including cancer, diabetes, cardiovascular disease, lung disease, mental health, and neurological disorders are responsible for 75% of deaths worldwide. New ...

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...